BACKGROUND OF THE INVENTION
1. Technical Field of the Invention
The present invention relates to new uses of compounds, particularly a diterpenoid Galanal B, in the regulation of blood glucose levels.
2. Background
Glucagon-like peptide-1 (GLP-1) analogues are a new class of hypoglycemic agents.